These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12431202)

  • 1. Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNA.
    Morrissey DV; Lee PA; Johnson DA; Overly SL; McSwiggen JA; Beigelman L; Mokler VR; Maloney L; Vargeese C; Bowman K; O'Brien JT; Shaffer CS; Conrad A; Schmid P; Morrey JD; Macejak DG; Pavco PA; Blatt LM
    J Viral Hepat; 2002 Nov; 9(6):411-8. PubMed ID: 12431202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial screening and intracellular antiviral activity of hairpin ribozymes directed against hepatitis B virus.
    zu Putlitz J; Yu Q; Burke JM; Wands JR
    J Virol; 1999 Jul; 73(7):5381-7. PubMed ID: 10364285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
    Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX
    World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains.
    Ren GL; Fang Y; Ma HH; Lei YF; Wang D; Xu MC; Wang PZ; Huang CX; Nie OH; Sun YT; Bai XF
    Antivir Ther; 2007; 12(6):865-76. PubMed ID: 17926641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatitis B virus by hammerhead ribozyme targeted to the poly(A) signal sequence in cultured cells.
    Feng Y; Kong YY; Wang Y; Qi GR
    Biol Chem; 2001 Apr; 382(4):655-60. PubMed ID: 11405228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
    Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
    Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
    Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of lamivudine-resistant hepatitis B virus by allele-specific RNAi.
    Teng X; Xu WZ; Hao ML; Fang Y; Zhao YX; Chen SJ; Li D; Gu HX
    J Virol Methods; 2010 Sep; 168(1-2):6-12. PubMed ID: 20403386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular inhibition of the replication of hepatitis B virus by hammerhead ribozymes.
    Feng Y; Kong YY; Wang Y; Qi GR
    J Gastroenterol Hepatol; 2001 Oct; 16(10):1125-30. PubMed ID: 11686839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the 'a' epitope of the surface antigen are sensitive to ganciclovir.
    Oon CJ; Chen WN; Lim N; Koh S; Lim GK; Leong AL; Tan GS
    Antiviral Res; 1999 Apr; 41(3):113-8. PubMed ID: 10320044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiviral effect of hepatitis B virus S gene-specific anti-gene locked nucleic acid in transgenic mice].
    Xiao SR; Xu GD; Wei WJ; Peng B; Deng YB
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):17-22. PubMed ID: 29804357
    [No Abstract]   [Full Text] [Related]  

  • 13. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
    Hu K; Huang Y; Mu J; Cheng Z; Zhu X
    Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy.
    Li D; Xu DZ; Choi BC; Men K; Zhang JX; Lei XY; Yan YP
    J Med Virol; 2005 Jun; 76(2):203-7. PubMed ID: 15834875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants.
    Suzuki F; Akuta N; Suzuki Y; Sezaki H; Arase Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Satoh J; Watahiki S; Kumada H
    J Med Virol; 2006 Mar; 78(3):341-52. PubMed ID: 16419116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
    Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
    Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.
    Bartholomew MM; Jansen RW; Jeffers LJ; Reddy KR; Johnson LC; Bunzendahl H; Condreay LD; Tzakis AG; Schiff ER; Brown NA
    Lancet; 1997 Jan; 349(9044):20-2. PubMed ID: 8988118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment.
    Moriconi F; Colombatto P; Coco B; Ciccorossi P; Oliveri F; Flichman D; Maina AM; Sacco R; Bonino F; Brunetto MR
    J Antimicrob Chemother; 2007 Aug; 60(2):341-9. PubMed ID: 17567633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
    Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
    Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.
    Wooddell CI; Yuen MF; Chan HL; Gish RG; Locarnini SA; Chavez D; Ferrari C; Given BD; Hamilton J; Kanner SB; Lai CL; Lau JYN; Schluep T; Xu Z; Lanford RE; Lewis DL
    Sci Transl Med; 2017 Sep; 9(409):. PubMed ID: 28954926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.